Cancer Research UK appoints new trustee

Cancer Research UK
Professor Sir Bruce Ponder

Cancer Research UK has announced the appointment of Professor Sir Bruce Ponder, FRCP, FMedSci, FRS as a Trustee.

Professor Sir Bruce Ponder is Emeritus Professor of Oncology at Cambridge University. He was formerly Li Ka Shing Professor of Oncology, Founding Director of the Cancer Research UK Cambridge Research Institute and of the Cambridge Cancer Centre. He was also co-Director of both the Hutchison/MRC Research Centre and the Strangeways Research Laboratories for Genetic Epidemiology. He was knighted in 2008 for services to medicine.

Sir Bruce trained in medicine in London and completed a PhD at the Imperial Cancer Research Fund, latterly the Cancer Research UK London Research Institute. He studied medical oncology at the Dana Farber Cancer Institute, Harvard University.

He was an early researcher in the genetics of susceptibility to cancer, establishing clinics to help families with a strong history of cancer, and identifying a gene for one type of familial thyroid cancer. With others, he set up and was the first Chair of the International Consortium that was behind the discovery of the BRCA1 and BRCA2 breast cancer genes. In 2007 his research group published the first cancer genome-wide association study in breast cancer.

Michael Pragnell, Chairman of Cancer Research UK, said: “I’m very pleased to welcome Sir Bruce to our governing Council. He is an internationally renowned cancer researcher and his extensive knowledge and experience will be hugely valuable to the Charity. I much look forward to working with him.”

All Trustee roles at Cancer Research UK are unremunerated.


For more information, please contact the Cancer Research UK press office on 020 3469 8300 or out of hours on 07050 264 059.